Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage

被引:74
作者
Yano, K
Oura, H
Detmar, M
机构
[1] Massachusetts Gen Hosp, Dept Dermatol, CBRC, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
关键词
VEGF; skin aging; endothelium;
D O I
10.1046/j.1523-1747.2002.01752.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Chronic ultraviolet-B irradiation of the skin results in epidermal hyperplasia, degradation of extracellular matrix molecules, and formation of wrinkles. To characterize the biologic role of the vascular system in the mediation of ultraviolet-B-induced skin damage, we performed quantitative analyses of cutaneous blood vessels of mice after 10 wk of ultraviolet-B irradiation. Skin vascularization was greatly increased after chronic ultraviolet-B exposure with a significant increase of both the number and the size of dermal blood vessels, associated with upregulation of vascular endothelial growth factor expression in the hyperplastic epidermis. To directly study whether inhibition of angiogenesis may diminish ultraviolet-B-induced cutaneous damage, wild-type and transgenic mice with skin-specific overexpression of the endogenous angiogenesis inhibitor thrombospondin-1 were subjected to the same ultraviolet-B irradiation regimen. Ultraviolet-B-irradiated thrombospondin-1 transgenic mice showed a significantly reduced skin vascularization, decreased endothelial cell proliferation, and increased endothelial cell apoptosis rates, compared with wild-type mice. Moreover, dermal photo-damage and wrinkle formation were greatly reduced in thrombospondin-1 transgenic mice. These results reveal an important role of the cutaneous vascular system in mediating ultraviolet-B-induced skin damage and suggest inhibition of angiogenesis as a potential new approach for the prevention of chronic cutaneous photo-damage.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 45 条
[1]   Thrombospondin type 1 repeats interact with matrix metalloproteinase 2 - Regulation of metalloproteinase activity [J].
Bein, K ;
Simons, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :32167-32173
[2]   Epidermal proliferation but not the quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis [J].
Berton, TR ;
Mitchell, DL ;
Fischer, SM ;
Locniskar, MF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) :340-347
[3]   Molecular regulation of UVB-induced cutaneous angiogenesis [J].
Bielenberg, DR ;
Bucana, CD ;
Sanchez, R ;
Donawho, CK ;
Kripke, ML ;
Fidler, IJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (05) :864-872
[4]   AN ANIMAL-MODEL OF SOLAR-AGED SKIN - HISTOLOGICAL, PHYSICAL, AND VISIBLE CHANGES IN UV-IRRADIATED HAIRLESS MOUSE SKIN [J].
BISSETT, DL ;
HANNON, DP ;
ORR, TV .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1987, 46 (03) :367-&
[5]   Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization [J].
Bleuel, K ;
Popp, S ;
Fusenig, NE ;
Stanbridge, EJ ;
Boukamp, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2065-2070
[7]   Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes [J].
Brauchle, M ;
Funk, JO ;
Kind, P ;
Werner, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) :21793-21797
[8]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[9]   INCREASED EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN BULLOUS PEMPHIGOID, DERMATITIS-HERPETIFORMIS, AND ERYTHEMA MULTIFORME [J].
BROWN, LF ;
HARRIST, TJ ;
YEO, KT ;
STAHLEBACKDAHL, M ;
JACKMAN, RW ;
BERSE, B ;
TOGNAZZI, K ;
DVORAK, HF ;
DETMAR, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (05) :744-749
[10]  
BROWN LF, 1995, J IMMUNOL, V154, P2801